The global cardiac biomarker diagnostic kits market was valued at US$ 2,100 Mn in 2017. It is anticipated to reach US$ 3,300 Bn by 2026, expanding at a CAGR of 5.4% from 2018 to 2026. Launch of high sensitivity cardiac biomarker kits, focus on research and development and new product launches by market players, strategic acquisitions and partnerships to enhance their geographic presence, rising prevalence of cardiac diseases, and shift in focus of the population toward treatment of chronic and lifestyle diseases are fuelling the market.
The global cardiac biomarker diagnostic kits market has been segmented based on product, disease indication, testing, end-user, and region. Based on product, the troponin test kits segment is projected to lead the market, in terms of revenue, and dominate the market during the forecast period, followed by the BNP test kit segment. It is anticipated to remain dominant during the forecast period. Expansion of the segment can be attributed to a rise in the demand for performing high sensitive troponin assay. Furthermore, increase in applications, owing to the growing focus on research in troponin to understand the interactions, and increasing number of studies on troponin interactions to streamline the cardiac biomarker development process are driving the segment.
In terms of end-user, the global cardiac biomarker diagnostic kits market has been categorized into hospitals, diagnostic centers, clinics, and others. Hospitals & diagnostic laboratories are an important channel for the usage of diagnostic products & offer a range of diagnosis solutions. They are an important channel for the usage of diagnostic products.
In terms of disease indication, the global cardiac biomarker diagnostic kits market has been classified into angina pectoris, myocardial infraction, cardiac heart failure, and others. The angina pectoris segment accounted for a major share of the global cardiac biomarker diagnostic kits market in 2017. The global market for cardiac biomarker diagnostic kits is driven primarily by the growing prevalence of cardiac disease that can lead to incidence of myocardial infraction, cardiac heart failure, and angina pectoris. Additionally, the concomitant rise in the associated mortality in worldwide population is fueling the demand for cardiac biomarker diagnostic kits. Rising demand for laboratory investigation for the diagnosis of cardiac diseases is propelling the market.
In terms of region, the global cardiac biomarker diagnostic kits market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global cardiac biomarker diagnostic kits market, in terms of revenue, in 2017. It is projected to maintain its dominance during the forecast period. Presence of well-established players in the region and increasing research and development activities by these players are key attributable factors for North America’s dominance of the global cardiac biomarker diagnostic kits market. Asia Pacific is projected to be a highly attractive market for cardiac biomarker diagnostic kits, and the region is likely to exhibit a high attractiveness index. The market in Asia Pacific is projected to expand at a high CAGR during the forecast period, due to the rise of cardiac disease diagnosis which are expanding in countries in Asia Pacific. This, in turn, is attributable to well-developed health care infrastructure, increase in health care expenditure, and rise in the number of local manufacturers providing innovative products at lower cost. The market in Latin America is expected to expand at a moderate pace during the forecast period.
Major players operating in the global cardiac biomarker diagnostic kits market are Abbott Laboratories, Hoffmann-La Roche AG, Bio-Rad Laboratories, Danaher Corporation, Siemens Healthineers, Thermo Fisher Scientific, bioMérieux, Randox Laboratories Ltd., and Ortho Clinical Diagnostics. They account for a significant share of the global market. The market is characterized by a large number of acquisitions, which has led to market consolidation and increasing dominance of the top players. In 2017, Abbott completed its acquisition of Alere, concluding a deal first announced in February 2016. Companies operating in the cardiac biomarker diagnostic kits are focused on increasing their geographic presence by means of strategic collaborations with leading players in their respective domains and geographies.
The global cardiac biomarker diagnostic kits market has been segmented as follows:
|
Disease Indication |
|
|
Product |
|
|
Testing |
|
|
End-user |
|
|
Region |
|
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Cardiac Biomarker Diagnostic Kits Market
4. Market Overview
4.1. Introduction
4.1.1. Products Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, 2016–2026
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Regulatory Scenario by Region/Globally
5.2. Key Mergers & Acquisitions
5.3. Reimbursement Scenario
5.4. Cardiac Diseases Prevalence Rate Globally with Key Countries
5.5. Top 3 players operating in the market space
6. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016–2026
6.3.1. Troponin Test Kits
6.3.2. CK-MB Test Kits
6.3.3. Myoglobin Test Kits
6.3.4. BNP Test Kit
6.3.5. C-reactive Protein (hsCRP)
6.3.6. Others
6.4. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product
7. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by Testing
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016–2026
7.3.1. Laboratory Testing
7.3.2. Pont-of-care Testing
7.4. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Testing
8. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by Disease Indication
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016–2026
8.3.1. AngiStent Type Pectoris
8.3.2. Myocardial Infraction
8.3.3. Cardiac Heart Failure
8.3.4. Other
8.4. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication
9. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016–2026
9.3.1. Hospitals
9.3.2. Clinics
9.3.3. Diagnostic Laboratory
9.3.4. Others
9.4. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by End-user
10. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Region
11. North America Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016–2026
11.2.1. Troponin Test Kits
11.2.2. CK-MB Test Kits
11.2.3. Myoglobin Test Kits
11.2.4. BNP Test Kit
11.2.5. C-reactive Protein (hsCRP)
11.2.6. Others
11.3. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016–2026
11.3.1. Laboratory Testing
11.3.2. Pont-of-care Testing
11.4. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016–2026
11.4.1. AngiStent Type Pectoris
11.4.2. Myocardial Infraction
11.4.3. Cardiac Heart Failure
11.4.4. Other
11.5. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016–2026
11.5.1. Hospitals
11.5.2. Clinics
11.5.3. Diagnostic Laboratory
11.5.4. Others
11.6. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country, 2016–2026
11.6.1. U.S.
11.6.2. Canada
11.7. North America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Testing
11.7.3. By Disease Indication
11.7.4. By End-user
11.7.5. By Country
12. Europe Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016–2026
12.2.1. Troponin Test Kits
12.2.2. CK-MB Test Kits
12.2.3. Myoglobin Test Kits
12.2.4. BNP Test Kit
12.2.5. C-reactive Protein (hsCRP)
12.2.6. Others
12.3. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016–2026
12.3.1. Laboratory Testing
12.3.2. Pont-of-care Testing
12.4. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016–2026
12.4.1. AngiStent Type Pectoris
12.4.2. Myocardial Infraction
12.4.3. Cardiac Heart Failure
12.4.4. Other
12.5. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016–2026
12.5.1. Hospitals
12.5.2. Clinics
12.5.3. Diagnostic Laboratory
12.5.4. Others
12.6. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country/Sub-region, 2016–2026
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Testing
12.7.3. by Disease Indication
12.7.4. by End-user
12.7.5. by Country/Sub-region
13. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016–2026
13.2.1. Troponin Test Kits
13.2.2. CK-MB Test Kits
13.2.3. Myoglobin Test Kits
13.2.4. BNP Test Kit
13.2.5. C-reactive Protein (hsCRP)
13.2.6. Others
13.3. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016–2026
13.3.1. Laboratory Testing
13.3.2. Pont-of-care Testing
13.4. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016–2026
13.4.1. AngiStent Type Pectoris
13.4.2. Myocardial Infraction
13.4.3. Cardiac Heart Failure
13.4.4. Other
13.5. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016–2026
13.5.1. Hospitals
13.5.2. Clinics
13.5.3. Diagnostic Laboratory
13.5.4. Others
13.6. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country/Sub-region, 2016–2026
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Testing
13.7.3. By Disease Indication
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016–2026
14.2.1. Troponin Test Kits
14.2.2. CK-MB Test Kits
14.2.3. Myoglobin Test Kits
14.2.4. BNP Test Kit
14.2.5. C-reactive Protein (hsCRP)
14.2.6. Others
14.3. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016–2026
14.3.1. Laboratory Testing
14.3.2. Pont-of-care Testing
14.4. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016–2026
14.4.1. AngiStent Type Pectoris
14.4.2. Myocardial Infraction
14.4.3. Cardiac Heart Failure
14.4.4. Other
14.5. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016–2026
14.5.1. Hospitals
14.5.2. Clinics
14.5.3. Diagnostic Laboratory
14.5.4. Others
14.6. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country/Sub-region, 2016–2026
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Testing
14.7.3. By Disease Indication
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016–2026
15.2.1. Troponin Test Kits
15.2.2. CK-MB Test Kits
15.2.3. Myoglobin Test Kits
15.2.4. BNP Test Kit
15.2.5. C-reactive Protein (hsCRP)
15.2.6. Others
15.3. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016–2026
15.3.1. Laboratory Testing
15.3.2. Pont-of-care Testing
15.4. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016–2026
15.4.1. AngiStent Type Pectoris
15.4.2. Myocardial Infraction
15.4.3. Cardiac Heart Failure
15.4.4. Other
15.5. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016–2026
15.5.1. Hospitals
15.5.2. Clinics
15.5.3. Diagnostic Laboratory
15.5.4. Others
15.6. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country/Sub-region, 2016–2026
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis
15.7.1. By Product
15.7.2. By Testing
15.7.3. By Disease Indication
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (by Tier and Size of companies)
16.2. Market Share Analysis by Company (2017)
16.3. Competitive Business Strategies
16.4. Company Profiles
16.4.1. Abbott Laboratories Ltd.
16.4.1.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.4.1.2. Business Overview
16.4.1.3. Product Portfolio
16.4.1.4. Financial Overview
16.4.1.5. SWOT Analysis
16.4.2. Hoffmann-La Roche AG
16.4.2.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.4.2.2. Business Overview
16.4.2.3. Product Portfolio
16.4.2.4. Financial Overview
16.4.2.5. SWOT Analysis
16.4.3. Bio-Rad Laboratories
16.4.3.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.4.3.2. Business Overview
16.4.3.3. Product Portfolio
16.4.3.4. Financial Overview
16.4.3.5. SWOT Analysis
16.4.4. Danaher Corporation
16.4.4.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.4.4.2. Business Overview
16.4.4.3. Product Portfolio
16.4.4.4. Financial Overview
16.4.4.5. SWOT Analysis
16.4.5. Seimens Healthineers
16.4.5.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.4.5.2. Business Overview
16.4.5.3. Product Portfolio
16.4.5.4. Financial Overview
16.4.5.5. SWOT Analysis
16.4.6. Thermofisher Scientific
16.4.6.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.4.6.2. Business Overview
16.4.6.3. Product Portfolio
16.4.6.4. Financial Overview
16.4.6.5. SWOT Analysis
16.4.7. bioMérieux
16.4.7.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.4.7.2. Business Overview
16.4.7.3. Product Portfolio
16.4.7.4. Financial Overview
16.4.7.5. SWOT Analysis
16.4.8. Ortho Clinical Diagnostics
16.4.8.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.4.8.2. Business Overview
16.4.8.3. Product Portfolio
16.4.8.4. Financial Overview
16.4.8.5. SWOT Analysis
List of Tables
Table 01: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 02: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 03: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016–2026
Table 04: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 05: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 06: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 07: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 08: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016–2026
Table 09: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 10: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 11: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 12: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 13: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016–2026
Table 14: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 15: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 16: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 17: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 18: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016–2026
Table 19: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 20: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 21: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 22: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 23: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016–2026
Table 24: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 25: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 26: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 27: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 28: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016–2026
Table 29: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 30: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
List of Figures
Figure 01: Global Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2017 and 2026
Figure 02: Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2018–2026
Figure 03: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by Troponin Test Kits, 2016–2026
Figure 04: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by CK-MB Test Kits, 2016–2026
Figure 05: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by Myoglobin Test Kits, 2016–2026
Figure 06: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by BNP Test Kit, 2016–2026
Figure 07: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by C-reactive Protein (hsCRP), 2016–2026
Figure 08: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by Other Biomarkers, 2016–2026
Figure 09: Global Cardiac Biomarker Diagnostic Kits Market Value Share, by Disease Indication, 2017 and 2026
Figure 10: Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication, 2018–2026
Figure 11: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by Angina Pectoris, 2016–2026
Figure 12: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by Myocardial Infraction (MI), 2016–2026
Figure 13: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by Cardiac Heart Failure, 2016–2026
Figure 14: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 15: Global Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2017 and 2026
Figure 16: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Laboratory Testing, 2016–2026
Figure 17: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Pont-of-care testing, 2016–2026
Figure 18: Global Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2018–2026
Figure 19: Global Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2017 and 2026
Figure 20: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Hospitals, 2016–2026
Figure 21: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Clinics, 2016–2026
Figure 22: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Diagnostic Laboratory, 2016–2026
Figure 23: Global Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2018–2026
Figure 24: Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Region, 2017 and 2026
Figure 25: Global Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis by Region, 2018–2026
Figure 26: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 27: North America Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2017 and 2026
Figure 28: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2018–2026
Figure 29: North America Cardiac Biomarker Diagnostic Kits Market Value Share, by Disease Indication, 2017 and 2026
Figure 30: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication, 2018–2026
Figure 31: North America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2017 and 2026
Figure 32: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2018–2026
Figure 33: North America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2017 and 2026
Figure 34: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2018–2026
Figure 35: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country, 2018–2026
Figure 36: North America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country, 2017 and 2026
Figure 37: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 38: Europe Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2017 and 2026
Figure 39: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2018–2026
Figure 40: Europe Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2017 and 2026
Figure 41: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2018–2026
Figure 42: Europe Cardiac Biomarker Diagnostic Kits Market Value Share, by Disease Indication, 2017 and 2026
Figure 43: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication, 2018–2026
Figure 44: Europe Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2017 and 2026
Figure 45: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2018–2026
Figure 46: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 47: Europe Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 48: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 49: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2017 and 2026
Figure 50: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2018–2026
Figure 51: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share, by Disease Indication, 2017 and 2026
Figure 52: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication, 2018–2026
Figure 53: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2017 and 2026
Figure 54: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2018–2026
Figure 55: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2017 and 2026
Figure 56: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2018–2026
Figure 57: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 58: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 59: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 60: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2017 and 2026
Figure 61: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2018–2026
Figure 62: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share, by Disease Indication, 2017 and 2026
Figure 63: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication, 2018–2026
Figure 64: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2017 and 2026
Figure 65: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2018–2026
Figure 66: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2017 and 2026
Figure 67: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2018–2026
Figure 68: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 69: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 70: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 71: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2017 and 2026
Figure 72: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2018–2026
Figure 73: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Share, by Disease Indication, 2017 and 2026
Figure 74: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication, 2018–2026
Figure 75: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2017 and 2026
Figure 76: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2018–2026
Figure 77: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2017 and 2026
Figure 78: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2018–2026
Figure 79: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country, 2018–2026
Figure 80: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country, 2017 and 2026
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Cardiac Biomarker Diagnostic Test Kits Market
*86 figures and 60 tables includes